CYP2A6 phenotype in a Spanish population:: Influence of gender, age and smoking

被引：0
|
作者：
Carcas de Benavides, C. [1 ]
Fanlo Villacampa, A. [1 ]
Soriano Guillén, A. [1 ]
Vicente Romero, J. [1 ]
Arenaz Villalba, I. [1 ]
Mayayo Dehesa, E. [1 ]
Sinués Porta, B. [1 ]
机构：
[1] Univ Zaragoza, Sch Med, Pharmacol Unit, E-50009 Zaragoza, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2006年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [41] CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking
    Wiratchanee Mahavorasirikul
    Wichittra Tassaneeyakul
    Soisagwan Satarug
    Ronnatrai Reungweerayut
    Chacrin Na-Bangchang
    Kesara Na-Bangchang
    European Journal of Clinical Pharmacology, 2009, 65 : 377 - 384
  • [42] Lack of correlation between CYP2A6 genotype and smoking habits
    Schulz, TG
    Ruhnau, P
    Müller, M
    Bünger, J
    Ellie-hausen, HJ
    Hallier, E
    TOXICOLOGY, 2001, 164 (1-3) : 150 - 151
  • [43] Smoking behavior and related cancers:: The role of CYP2A6 polymorphisms
    Nakajima, Miki
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2007, 9 (06) : 538 - 544
  • [44] CYP2A6 metabolism in the development of smoking behaviors in young adults
    Olfson, Emily
    Bloom, Joseph
    Bertelsen, Sarah
    Budde, John P.
    Breslau, Naomi
    Brooks, Andrew
    Culverhouse, Robert
    Chan, Grace
    Chen, Li-Shiun
    Chorlian, David
    Dick, Danielle M.
    Edenberg, Howard J.
    Hartz, Sarah
    Hatsukami, Dorothy
    Hesselbrock, Victor M.
    Johnson, Eric O.
    Kramer, John R.
    Kuperman, Samuel
    Meyers, Jacquelyn L.
    Nurnberger, John
    Porjesz, Bernice
    Saccone, Nancy L.
    Schuckit, Marc A.
    Stitzel, Jerry
    Tischfield, Jay A.
    Rice, John P.
    Goate, Alison
    Bierut, Laura J.
    ADDICTION BIOLOGY, 2018, 23 (01) : 437 - 447
  • [45] Associations of CYP2A6 Gene Polymorphism with Smoking Status Among Jordanians: Gender-related Differences
    Hammad, Hana M.
    Imraish, Amer
    Azab, Belal
    Best, Al M.
    Khader, Yousef S.
    Zihlif, Malek
    CURRENT DRUG METABOLISM, 2019, 20 (09) : 765 - 770
  • [46] Influence of CYP2A6 Genetic Variation, Nicotine Dependence Severity, and Treatment on Smoking Cessation Success
    Chenoweth, Meghan J.
    Lerman, Caryn
    Knight, Jo
    Tyndale, Rachel F.
    NICOTINE & TOBACCO RESEARCH, 2023, 25 (06) : 1207 - 1211
  • [47] Phenotypic polymorphism of CYP2A6 activity in a Chinese population
    Xu, P
    Huang, SL
    Zhu, RH
    Han, XM
    Zhou, HH
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (05) : 333 - 337
  • [48] A pilot study characterizing two novel CYP2A6 alleles, CYP2A6*7 and CYP2A6*8, in vivo.
    Xu, C
    Rao, Y
    Xu, B
    Hoffmann, E
    Sellers, EM
    Tyndale, RF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P35 - P35
  • [49] Phenotypic polymorphism of CYP2A6 activity in a Chinese population
    Ping Xu
    Song-Lin Huang
    Rong-Hua Zhu
    Xing-Mei Han
    Hong-Hao Zhou
    European Journal of Clinical Pharmacology, 2002, 58 : 333 - 337
  • [50] Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C
    Ariyoshi, N
    Takahashi, Y
    Miyamoto, M
    Umetsu, Y
    Daigo, S
    Tateishi, T
    Kobayashi, S
    Mizorogi, Y
    Loriot, MA
    Stücker, I
    Beaune, P
    Kinoshita, M
    Kamataki, T
    PHARMACOGENETICS, 2000, 10 (08): : 687 - 693
12345